Changes in Lung Volume and Ventilation during Surfactant Treatment in Ventilated Preterm Infants

Abstract

Surfactant treatment in HFOV preterm infants with RDS causes a rapid increase and subsequent stabilization of lung volume, which is most prominent in dependent lung regions. It increased maximal compliance, but this effect is only reached at lower airway pressures.